Search results
Maker of COVID vaccines and naloxone exits Baltimore with sale of plant
The Baltimore Banner· 5 days agoGaithersburg-based Emergent BioSolutions is officially leaving Baltimore after a tumultuous stretch...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via AOL· 7 days agoAstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 3 days agoEven if that target proves overly optimistic, much of the negative impact of the patent cliff could be offset by these new products and indications....
3 Undervalued Pharma Stocks to Buy for Dividends and Capital Gains
InvestorPlace· 14 hours agoThere are multiple reasons to consider exposure to pharmaceutical stocks for the long-term...
Gateway - Quartz
Quartz· 7 days agoPharma giant AstraZeneca aims to increase its revenue by a whopping 75% in 2030, up from the $45.8 billion it generated in 2023 — just as it pulls its COVID
Merck's (MRK) 21-Valent Pneumococcal Jab Gets FDA Approval
Zacks via Yahoo Finance· 7 days agoMerck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive/V116, becomes the first PCV...
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market...
Morningstar· 5 days agoFN Media Group News Commentary - The National Cancer Institute’s (NCI) funding of research projects is predicted to empower the Pancreatic Cancer Market to grow. Unlike traditional therapeutic ...
Here's Why Eli Lilly (LLY) is Probably the Best Drug Stock Now
Zacks via Yahoo Finance· 5 days agoConclusion While other large drugmakers face continued challenges, Lilly has stayed strong. Pfizer...
Unveiling the Medical Democide in the UK
Mercola· 3 days ago"Playing God: An Investigation into Medical Democide in the UK" is a documentary film that explores allegations of harmful medical practices and policies in the U.K. health care system. Directed ...
Emergent BioSolutions to sell Baltimore plant, shed hundreds more workers in ongoing restructuring -...
The Business Journals· 5 days agoEmergent BioSolutions Inc. (NYSE: EBS) has inked a deal to sell one of its Baltimore plants, its...
